Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity

NCT07220642 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07220642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 5, 2025
Completion date
June 29, 2027
Enrollment
300 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight